ArticleJournal of nanobiotechnology2025

Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer.

Chenlin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.